The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.

Evidence has indicated that viral infection increases the risk of developing asthma. Although the association of human parvovirus B19 (B19V) or human bocavirus (HBoV) with respiratory diseases has been reported, little is known about the influence of the B19V-VP1u and HBoV-VP1u proteins on the sympt...

Full description

Bibliographic Details
Main Authors: Shyh-Ren Chiang, Chia-Yun Lin, Der-Yuan Chen, Hui-Fang Tsai, Xin-Ci Lin, Tsai-Ching Hsu, Bor-Show Tzang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0216799
_version_ 1818404127279939584
author Shyh-Ren Chiang
Chia-Yun Lin
Der-Yuan Chen
Hui-Fang Tsai
Xin-Ci Lin
Tsai-Ching Hsu
Bor-Show Tzang
author_facet Shyh-Ren Chiang
Chia-Yun Lin
Der-Yuan Chen
Hui-Fang Tsai
Xin-Ci Lin
Tsai-Ching Hsu
Bor-Show Tzang
author_sort Shyh-Ren Chiang
collection DOAJ
description Evidence has indicated that viral infection increases the risk of developing asthma. Although the association of human parvovirus B19 (B19V) or human bocavirus (HBoV) with respiratory diseases has been reported, little is known about the influence of the B19V-VP1u and HBoV-VP1u proteins on the symptoms of asthma. Herein, we investigated the systemic influence of subcutaneously injected B19V-VP1u and HBoV-VP1u recombinant proteins in an OVA-sensitized asthmatic mouse model. A significantly higher Penh ratio and IgE level were detected in the serum, bronchoalveolar lavage fluid (BALF) and the supernatant of a lymphocyte culture from mice treated with HBoV-VP1u or B19V-VP1u than in a lymphocyte culture from OVA-sensitized mice. Significantly higher levels of serum and BALF IgE, total IgG, IgG1, OVA-specific IgE and OVA-specific IgG1 were detected in mice treated with HBoV-VP1u or B19V-VP1u than in OVA-sensitized mice. Conversely, a significantly lower IgG2a level was detected in mice from the HBoV-VP1u or B19V-VP1u groups than in mice from the OVA group. The mice treated with HBoV-VP1u or B19V-VP1u exhibited more significant lung inflammatory indices, including elevated serum and BALF IL-4, IL-5, IL-10 and IL-13 levels; BALF lymphocyte, neutrophil and eosinophil counts, MMP-9 and MMP-2 activity; and the amount of lymphocyte infiltration, relative to those in the control mice or in those sensitized with OVA. These findings demonstrate that the subcutaneous injection of HBoV-VP1u or B19V-VP1u proteins in OVA-sensitized mice result in elevated asthmatic indices and suggest that human parvoviruses may increase the risk of developing airway inflammation in a mouse model of asthma.
first_indexed 2024-12-14T08:35:13Z
format Article
id doaj.art-514ce7f24dbf433a80583550666abcad
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T08:35:13Z
publishDate 2019-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-514ce7f24dbf433a80583550666abcad2022-12-21T23:09:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01145e021679910.1371/journal.pone.0216799The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.Shyh-Ren ChiangChia-Yun LinDer-Yuan ChenHui-Fang TsaiXin-Ci LinTsai-Ching HsuBor-Show TzangEvidence has indicated that viral infection increases the risk of developing asthma. Although the association of human parvovirus B19 (B19V) or human bocavirus (HBoV) with respiratory diseases has been reported, little is known about the influence of the B19V-VP1u and HBoV-VP1u proteins on the symptoms of asthma. Herein, we investigated the systemic influence of subcutaneously injected B19V-VP1u and HBoV-VP1u recombinant proteins in an OVA-sensitized asthmatic mouse model. A significantly higher Penh ratio and IgE level were detected in the serum, bronchoalveolar lavage fluid (BALF) and the supernatant of a lymphocyte culture from mice treated with HBoV-VP1u or B19V-VP1u than in a lymphocyte culture from OVA-sensitized mice. Significantly higher levels of serum and BALF IgE, total IgG, IgG1, OVA-specific IgE and OVA-specific IgG1 were detected in mice treated with HBoV-VP1u or B19V-VP1u than in OVA-sensitized mice. Conversely, a significantly lower IgG2a level was detected in mice from the HBoV-VP1u or B19V-VP1u groups than in mice from the OVA group. The mice treated with HBoV-VP1u or B19V-VP1u exhibited more significant lung inflammatory indices, including elevated serum and BALF IL-4, IL-5, IL-10 and IL-13 levels; BALF lymphocyte, neutrophil and eosinophil counts, MMP-9 and MMP-2 activity; and the amount of lymphocyte infiltration, relative to those in the control mice or in those sensitized with OVA. These findings demonstrate that the subcutaneous injection of HBoV-VP1u or B19V-VP1u proteins in OVA-sensitized mice result in elevated asthmatic indices and suggest that human parvoviruses may increase the risk of developing airway inflammation in a mouse model of asthma.https://doi.org/10.1371/journal.pone.0216799
spellingShingle Shyh-Ren Chiang
Chia-Yun Lin
Der-Yuan Chen
Hui-Fang Tsai
Xin-Ci Lin
Tsai-Ching Hsu
Bor-Show Tzang
The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.
PLoS ONE
title The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.
title_full The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.
title_fullStr The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.
title_full_unstemmed The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.
title_short The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.
title_sort effects of human parvovirus vp1 unique region in a mouse model of allergic asthma
url https://doi.org/10.1371/journal.pone.0216799
work_keys_str_mv AT shyhrenchiang theeffectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT chiayunlin theeffectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT deryuanchen theeffectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT huifangtsai theeffectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT xincilin theeffectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT tsaichinghsu theeffectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT borshowtzang theeffectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT shyhrenchiang effectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT chiayunlin effectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT deryuanchen effectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT huifangtsai effectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT xincilin effectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT tsaichinghsu effectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma
AT borshowtzang effectsofhumanparvovirusvp1uniqueregioninamousemodelofallergicasthma